arrow_right
Pivotal Study Design
PIVOTAL CLINICAL VALIDATION STUDY DESIGN
Percepta GSC was validated in a prospective, multicenter, blinded study on a combined cohort of 412 patients from AEGIS I1, AEGIS II1 and PERCEPTA Registry2. All patients met inclusion criteria and had an inconclusive bronchoscopy:
ADDITIONAL CLINICAL STUDIES
CONTACT A REP TO ORDER VERACYTE TESTING
Veracyte representatives are happy to assist you and to discuss how to integrate our tests into your practice.
First Name
Last Name
Email
Institution
Zip Code
Which Test Interests You?
More About You
Message
CONTACT REP
R E F E R E N C E S 
1. Silvestri GA et al. New England Journal of Medicine. 2015.
2. Lee HJ et al. Oral presentation at CHEST 2018.
© 2019 Veracyte, Inc. All rights reserved.